User-centred design, validation and clinical testing of an anti-choking mug for people with Parkinson’s disease.

User-centred design, validation and clinical testing of an anti-choking mug for people with Parkinson’s disease.

Publication date: Jun 19, 2024

Oropharyngeal dysphagia, or difficulty initiating swallowing, is a frequent problem in people with Parkinson’s disease (PD) and can lead to aspiration pneumonia. The efficacy of pharmacological options is limited. Postural strategies, such as a chin-down manoeuvre when drinking, have had some degree of success but may be difficult for people who have other limitations such as dementia or neck rigidity, to reproduce consistently. Using a user-centred design approach and a multidisciplinary team, we developed and tested an anti-choking mug for people with PD that helps angle the head in the optimum position for drinking. The design reflected anthropometric and ergonomic aspects of user needs with features including regulation of water flow rate and sip volume, an inner slope, a thickened handle and a wide base, which promoted a chin-down posture when used. Prototype testing using digital technology to compare neck flexion angles (the primary outcome), plus clinical outcomes assessed using standard tools (Swallowing Clinical Assessment Score in Parkinson’s Disease (SCAS-PD) and Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Parts II and III), found significant improvements in a range of parameters related to efficient swallowing and safe drinking when using the anti-choking mug versus a sham mug.

Open Access PDF

Concepts Keywords
Efficient Aged
Oropharyngeal Airway Obstruction
Parkinson Anti-choking mug
Pharmacological Aspiration
Pneumonia Chin-down manoeuvre
Deglutition
Deglutition Disorders
Female
Humans
Male
Middle Aged
Oropharyngeal dysphagia
Parkinson Disease
Parkinson’s disease
Posture
User-Centered Design
User-centred design

Semantics

Type Source Name
disease MESH choking
disease MESH Parkinson’s disease
disease MESH Oropharyngeal dysphagia
disease MESH aspiration pneumonia
drug DRUGBANK Spinosad
disease MESH dementia
drug DRUGBANK Water
disease MESH posture
disease MESH Movement Disorder
drug DRUGBANK Coenzyme M
disease MESH complications
disease MESH malnutrition
disease MESH death
drug DRUGBANK Levodopa
drug DRUGBANK Trestolone
disease MESH cognitive impairment
drug DRUGBANK Gold
drug DRUGBANK Oxygen
disease MESH stroke
disease MESH amyotrophic lateral sclerosis
pathway KEGG Amyotrophic lateral sclerosis
disease MESH myasthenia gravis
disease MESH Lambert Eaton syndrome
disease MESH abnormalities
disease MESH pneumonitis
disease MESH bronchitis
disease MESH asthma
pathway KEGG Asthma
disease MESH chronic obstructive pulmonary disease
disease MESH arrhythmia
disease MESH COVID 19
disease MESH lordosis
drug DRUGBANK Sodium lauryl sulfate
disease MESH dehydration
disease MESH orthostatic hypotension
disease MESH gastroparesis
disease MESH Parkinsonism
drug DRUGBANK Sulodexide
pathway KEGG Parkinson disease
disease MESH syndromes
drug DRUGBANK Dopamine
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *